Please provide your email address to receive an email when new articles are posted on . Patients with cancer and overweight or obesity had better outcomes with immune checkpoint inhibitors than ...

Patients with hepatitis C treated with combination therapy of pegylated interferon and ribavirin had better outcomes when taking a weight-based dosage of ribavirin compared to a flat dosage. This ...

The FDA recently approved the supplemental biologics license application for teclistamab (Tecvayli; Johnson & Johnson) to treat relapsed/refractory multiple myeloma on a biweekly dosing schedule.

Obesity can have a distinct impact on the absorption, effectiveness and excretion of antibiotics, medications that have been in use for more than 80 years, but only now have consensus guidelines been ...

(BOSTON, Oct. 29, 2004) – Twice as many African-American patients infected with the most difficult-to-treat form of chronic hepatitis C successfully cleared the virus when given a weight-based dose of ...

Q: Shouldn’t doctors take into account body size when prescribing drugs? As a small female, I worry about getting the same dosage of antibiotics as men who weigh 100 pounds more than I do. A: A ...